Yun Yen - 30 Jun 2025 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Reporting relationship: Director
Issuer ticker: LIXT
Reported as of: 30 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jul 2025, 11:52:58 UTC
Prior SEC filing: 02 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Yun Yen

Key filing fact

Yun Yen filed Form 4 for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) on 09 Jul 2025.

Key facts

This page summarizes Yun Yen's Form 4 filing for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).
2 reported transactions and 13 derivative rows are listed below.
Accepted by SEC: 09 Jul 2025, 11:52.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001684584 Primary reporting owner

Yen Yun

Relationship: Director
Address: 680 E. COLORADO BLVD., SUITE 180, PASADENA
Signature: /s/ Yun Yen
Signature date: 09 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LIXT transaction Derivative

Options to Purchase Common Stock

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 10,000
Exercise price: $0.9050
Footnotes: F1

LIXT transaction Derivative

Options to Purchase Common Stock

Award

Transaction value: $0
Shares: +11,632
Change %
Price: $0.000000
Shares after: 11,632
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 11,652
Exercise price: $0.9050
Footnotes: F2

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,777
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 8,777
Exercise price: $1.21

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,545
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 4,545
Exercise price: $2.33

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,786
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 5,786
Exercise price: $1.30

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,000
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 10,000
Exercise price: $2.37

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,527
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 4,527
Exercise price: $2.37

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,000
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 10,000
Exercise price: $7.45

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,000
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 10,000
Exercise price: $30.30

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,000
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 5,000
Exercise price: $32.10

LIXT holding Derivative

Warrants to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,263
Date: 30 Jun 2025
Ownership: By Sino-American Cancer FDD
Underlying class: Common
Underlying amount: 5,263
Exercise price: $57.00

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,333
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 3,333
Exercise price: $16.80

LIXT holding Derivative

Options to Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 833
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common
Underlying amount: 833
Exercise price: $66.00

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025.

Footnote F2

Effective June 30, 2025 the reporting person was granted stock options in aggregate of 11,632 vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .